Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia

SIMPLE SUMMARY: Despite recent progress achieved in the management of acute myeloid leukemia (AML), it remains a life-threatening disease with a poor prognosis, particularly in the elderly, having an average 5-year survival of approximately 28%. However, recent evidence suggests that immunotherapy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Aureli, Anna, Marziani, Beatrice, Sconocchia, Tommaso, Del Principe, Maria Ilaria, Buzzatti, Elisa, Pasqualone, Gianmario, Venditti, Adriano, Sconocchia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699368/
https://www.ncbi.nlm.nih.gov/pubmed/34944865
http://dx.doi.org/10.3390/cancers13246246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699368/
https://www.ncbi.nlm.nih.gov/pubmed/34944865
http://dx.doi.org/10.3390/cancers13246246

Ejemplares similares